Universidad Mayor San Simón, Cochabamba, Bolivia. Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01300975
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Universidad Mayor de San Simón | Universidad Mayor San Simón. Cochabamba, Bolivia.

Active Ingredients

Drugs in Phase 2 Trials (4)

antimony (1 trial)

benznidazole (Rochagan) (1 trial)

e1224 (1 trial)

ivermectin (stromectol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chagas Disease (Phase 2)

Leishmaniasis (Phase 2)

Leishmaniasis, Cutaneous (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4